Exposure to tachycardia (HR ≥ 100 bpm) | Exposure to low DAP (DAP ≤ 40 mmHg) | |||||
---|---|---|---|---|---|---|
HR | 95%CI | P value | HR | 95%CI | P value | |
Baseline variables | ||||||
Age, years | 1.02 | (1.01–1.03) | < 0.001 | 1.01 | (1.01–1.02) | < 0.001 |
Male | 0.81 | (0.69–0.94) | 0.004 | 0.85 | (0.73–0.98) | 0.026 |
BMI, kg/m2 | 0.99 | (0.98–1.00) | 0.075 | 0.99 | (0.98–1.00) | 0.097 |
CCU | 0.33 | (0.28–0.40) | < 0.001 | 0.32 | (0.27–0.38) | < 0.001 |
OASIS | 1.02 | (1.01–1.03) | < 0.001 | 1.02 | (1.02–1.03) | < 0.001 |
SOFA | 1.09 | (1.06–1.11) | < 0.001 | 1.08 | (1.05–1.11) | < 0.001 |
CCI | 1.10 | (1.06–1.13) | < 0.001 | 1.09 | (1.06–1.12) | < 0.001 |
Lactate, mmol/l | 1.11 | (1.09–1.13) | < 0.001 | 1.11 | (1.09–1.13) | < 0.001 |
Time-dependent variables | ||||||
Receiving IMV | 1.24 | (1.01–1.52) | 0.034 | 1.24 | (1.01–1.52) | 0.032 |
Receiving CRRT | 1.95 | (1.52–2.50) | < 0.001 | 1.81 | (1.41–2.32) | < 0.001 |
Use of vasopressors | 3.20 | (2.66–3.87) | < 0.001 | 3.15 | (2.61–3.80) | < 0.001 |
Tachycardia (≥ 100bmp) | 1.37 | (1.10–1.70) | < 0.001 | |||
Low DAP (≤ 40 mmHg) | 1.53 | (1.31–1.79) | < 0.001 |